Eli Lilly to spend up to $27 billion in new domestic plants amid Trump tariff threat
Drugmaker Eli Lilly plans to invest up to $27 billion to build four new pharmaceutical manufacturing sites in the U.S., the company announced Wednesday, a move that comes as President Trump is threatening import tariffs on pharmaceuticals.
The company said three of the future U.S. sites will focus on manufacturing active pharmaceutical ingredients. The fourth location will focus on injectable therapies.
Lilly said the sites have not been chosen yet, but the new locations will create 3,000 high-skilled jobs and employ 10,000 construction workers over the next five years.
Lilly previously invested $23 billion from 2020 to 2024 for new manufacturing sites in Wisconsin and North Carolina and expansions in its home state of Indiana.
Trump has been pressuring drugmakers and other industries to move manufacturing back to the U.S., and earlier this month said he was considering a 25 percent tariff on imports of pharmaceuticals and products like automobiles and semiconductors.
“Our confidence positions us to help reinvigorate domestic manufacturing, which will benefit hard-working American families and increase exports of medicines made in the U.S.A.," David A. Ricks, Lilly’s chairman and chief executive officer, said in a statement. "This bold move reflects our commitment to stay ahead of anticipated demand for safe, high-quality, FDA-approved medicines of the future."
Ricks credited Trump’s tax cuts with helping to fuel the company’s domestic investments and called for them to be extended, a key priority for Trump and congressional Republicans. Two separate budget resolutions have advanced in the House and Senate as part of kicking off the legislative process that lawmakers want to use to enact Trump’s agenda.
Lilly has been working to increase manufacturing capacity to meet the massive demand for its blockbuster diabetes and weight-loss drugs Zepbound and Mounjaro.
The drugs have been in shortage for years due to a lack of manufacturing capacity, though the Food and Drug Administration recently removed tirzepatide, the generic name for the drugs, off the shortage list.
-
Eli Lilly Plans to Spend $27 Billion on Four New U.S. Plants
Inc. - 4h -
Eli Lilly to spend $27 billion to expand U.S. manufacturing with four new sites
Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.MarketWatch - 3h -
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing reliance on foreign supply chains.CNBC - 1h -
Apple boosts U.S. investment plans with $500 billion pledge amid Trump tariff threat
Apple on Monday reaffirmed a commitment to spend hundreds of billions on U.S. soil in the coming years amid pressure from President Donald Trump.NBC News - 2d -
Apple announces $500 billion investment in US amid tariff threats that could affect the iPhone
Apple announced Monday that it plans to invest more than $500 billion in the United States over the next four years, including plans to hire 20,000 people and build a new server factory in TexasABC News - 2d -
Trump tariff threats rattle consumers
Welcome to The Hill's Business & Economy newsletter {beacon} Business & Economy Business & Economy The Big Story Consumer confidence dips in Trump’s first month A new survey found that ...The Hill - 4d -
Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up
The drug company is calling on insurers and federal programs to cover obesity as a chronic disease.MarketWatch - 8h -
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs
Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.CNBC - 6d
More from The Hill
-
Iran accelerating near-weapons-grade plutonium production: Watchdog
The International Atomic Energy Agency (IAEA) said Iran is taking steps to accelerate its near weapons-grade uranium in a broader effort to expand its capability for nuclear warfare, according to ...The Hill - 28m -
Jeffries: Cuomo comeback bid would draw 'a lot' of interest
House Minority Leader Hakeem Jeffries (D-N.Y.) said a potential political comeback bid from former New York Gov. Andrew Cuomo (D) would draw “a lot” of interest from constituents in the Empire ...The Hill - 28m -
Abortion pill maker enters legal battle over FDA rules
The country’s only manufacturer of generic abortion medication asked to be a part of the first legal fight over the procedure since President Donald Trump returned to office. The company, ...The Hill - 40m -
WHCA head: Public 'can no longer trust' pool reports under White House control
The head of the White House Correspondents Association (WHCA) says the public can no longer trust pool reports now that the reporters included in the small group will be controlled by President ...The Hill - 50m -
Supreme Court appears sympathetic toward straight woman’s ‘reverse discrimination’ case
The Supreme Court on Wednesday appeared to lean toward reviving a straight woman’s “reverse discrimination” case brought over claims she was passed over for a promotion and demoted in favor of gay ...The Hill - 52m
More in Politics
-
Iran accelerating near-weapons-grade plutonium production: Watchdog
The International Atomic Energy Agency (IAEA) said Iran is taking steps to accelerate its near weapons-grade uranium in a broader effort to expand its capability for nuclear warfare, according to ...The Hill - 28m -
Jeffries: Cuomo comeback bid would draw 'a lot' of interest
House Minority Leader Hakeem Jeffries (D-N.Y.) said a potential political comeback bid from former New York Gov. Andrew Cuomo (D) would draw “a lot” of interest from constituents in the Empire ...The Hill - 28m -
Abortion pill maker enters legal battle over FDA rules
The country’s only manufacturer of generic abortion medication asked to be a part of the first legal fight over the procedure since President Donald Trump returned to office. The company, ...The Hill - 40m -
WHCA head: Public 'can no longer trust' pool reports under White House control
The head of the White House Correspondents Association (WHCA) says the public can no longer trust pool reports now that the reporters included in the small group will be controlled by President ...The Hill - 50m -
Supreme Court appears sympathetic toward straight woman’s ‘reverse discrimination’ case
The Supreme Court on Wednesday appeared to lean toward reviving a straight woman’s “reverse discrimination” case brought over claims she was passed over for a promotion and demoted in favor of gay ...The Hill - 52m